In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCurrax is benefitting from weight loss drug demand, says CEO George HamptonGeorge Hampton, Currax CEO, joins CNBC's 'The Exchange' to discuss the company's weight loss drugs, how Contrave differs from other offerings, and more.
Persons:
George Hampton George Hampton